Published in
Springer (part of Springer Nature), Immunologic Research, 1(65), p. 419-422
DOI: 10.1007/s12026-016-8843-5
Links
Tools
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
Journal article published in 2016 by
Maurizio Benucci,
Francesca Li Gobbi,
Francesca Bandinelli,
Arianna Damiani,
Maria Infantino,
Valentina Grossi,
Mariangela Manfredi,
Simone Parisi 
,
Enrico Fusaro ,
Alberto Batticciotto,
Piercarlo Sarzi-Puttini,
Fabiola Atzeni,
Francesca Meacci
,
Enrico Fusaro ,
Alberto Batticciotto,
Piercarlo Sarzi-Puttini,
Fabiola Atzeni,
Francesca Meacci
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 